Harout Yacoub, MD
Nuclear Cardiology · New York, NYNPI 1932455847
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Medtronic at 35.8% of the total. Reporting peaked in 2022 at $500 and has fallen 72.9% since, to $136 in 2025.
Across 30 payments — averaging $53.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$573
- Abbott$415
- Abiomed$145
- Penumbra, Inc.$138
- Kestra Medical Technology Services, Inc.$136
- Bracco Diagnostics Inc.$79
- plus $117 from 3 others
Across 5 payments — averaging $7724.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Heartflow, Inc.$39K
What the payments were for
- Food & beverage$1,603100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 9 | $573 |
| Abbott | 11 | $415 |
| Abiomed | 1 | $145 |
| Penumbra, Inc. | 1 | $138 |
| Kestra Medical Technology Services, Inc. | 1 | $136 |
| Bracco Diagnostics Inc. | 1 | $79 |
| Novartis | 2 | $43 |
| Lantheus Medical Imaging, Inc. | 2 | $42 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$341
- Impella$145
- Indigo System$138
- Assure WCD$136
- MitraClip$134
How this compares
$1,603 in reported general payments places this provider in the 60th percentile of 21 nuclear cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $25,804 |
| Atorvastatin Calcium | 47 | $549 |
| Metoprolol Succinate | 23 | $419 |
| Losartan Potassium | 23 | $322 |
| Rosuvastatin Calcium | 12 | $145 |
| Furosemide | 26 | $139 |
| Carvedilol | 15 | $103 |
| Metoprolol Tartrate | 23 | $97 |
| Amlodipine Besylate | 14 | $94 |
| Hydrochlorothiazide | 15 | $87 |
| Lisinopril | 18 | $85 |
Paid to pharmacies, not to this prescriber.
Other nuclear cardiology in New York
- Klaus RentropNew York$5.6M
- Jonathan WeinsaftNew York$10K
- Margarita ChernovolenkoNew York$637
- Van-Hong NguyenNew York$99
- Lynne JohnsonNew York$59
- Kenneth LeeNew York$58
- Diwakar JainHawthorne$105K
- John AsheldWest Islip$24K
- Brian RiegelWilliamsville$23K
- Wilbur AsheldWest Islip$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.